Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 167

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 167
---
 as of June 30, 2024 (December 31, 2023 - $165,950).

On May 3, 2024, certain directors and officers of the Company purchased $700,000 aggregate principal amount of 2025 Convertible Notes on the same terms as the investors who were not related to the Company. On June 28, 2024, the 2025 Convertible Notes were converted into common shares of the Company at a conversion price of US$4.00 per share. RBx purchased $300,000 principal amount of 2025 Convertible Notes. James Quinlan, Chief Financial Officer of the Company, purchased $100,000 principal amount of 2025 Convertible Notes. Carolyn Bonner, President of the Company, purchased $25,000 principal amount of 2025 Convertible Notes.

On November 15, 2024, the Bokhari Trust, of which Dr. Raza Bokhari is a trustee, invested $594,000 in exchange for 144,000 units, consisting of 144,000 common shares and 144,000 Public Warrants as part of the Company’s initial public offering, James Quinlan, Chief Financial Officer of the Company, invested $111,360 in exchange for 24,000 units, consisting of 24,000 common shares and 24,000 Public Warrants as part of the Company’s U.S. initial public offering and Edward Brennan, Chief Scientific Officer of the Company, invested $111,360 in exchange for 24,000 units, consisting of 24,000 common shares and 24,000 Public Warrants as part of the Company’s U.S. initial public offering.

<div align='center'>- 117 -</div>

Interests of Management and Others in Material Transactions

Other than as disclosed above, none of the directors or executive officers of Medicus, or persons or companies that beneficially own, or control or direct, directly or indirectly, more than 10% of our outstanding common shares, or any associate or affiliate of any of the foregoing, has any material interest, direct or indirect, in any transactions in which Medicus has participated within the three years before the date of this offering circular, which has materially affected or is reasonably expected to materially affect Medicus.

Indebtedness of Directors and Executive Officers

As of the date of this offering circular, no director or officer of Medicus, or any associate or affiliate of any of them is indebted to